ArticleMedical oncology (Northwood, London, England)2022

IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.

Chih-Yi Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.